One-stop management of lung nodules and lung cancer: From multidisciplinary team to multidisciplinary doctor_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

 LIU Baodong ,  ZHI Xiuyi

Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, P. R. China;

Corresponding author：

ZHI Xiuyi, Email: xiuyizhi@aliyun.com

Keywords：

Multidisciplinary team; multidisciplinary doctor; lung nodules; lung cancer

DOI：

10.7507/1007-4848.202108037

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

In recent years, with the improvement of CT resolution, the reduction of radiation dose, the popularization of lung cancer screening and the enhancement of people's health awareness, the detection rate of lung nodules is higher and higher. Due to the close relationship between lung nodules and lung cancer, more and more attention has been paid to them. Although patients with early and middle stage lung cancer receive complete resection, all postoperative patients are at risk of recurrence and metastasis. Adjuvant or neoadjuvant therapy can improve the survival and reduce the recurrence and metastasis. Therefore, the multidisciplinary team, as the best model, provides a standardized and individualized plan for the diagnosis and treatment of lung nodules and lung cancer patients. However, in the clinical practice, the work efficiency of the multidisciplinary team is not high, and the participation rate of patients is low; therefore the multidisciplinary doctor model with thoracic surgeons as the mainstay is a reasonable alternative.

Citation： LIU Baodong, ZHI Xiuyi. One-stop management of lung nodules and lung cancer: From multidisciplinary team to multidisciplinary doctor. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2022, 29(3): 288-293. doi: 10.7507/1007-4848.202108037 Copy

1.	Devitt B, Philip J, McLachlan SA. Team dynamics, decision making, and attitudes toward multidisciplinary cancer meetings: Health professionals' perspectives. J Oncol Pract, 2010, 6(6): e17-e20.
2.	Rankin NM, Lai M, Miller D, et al. Cancer multidisciplinary team meetings in practice: Results from a multi-institutional quantitative survey and implications for policy change. Asia Pac J Clin Oncol, 2018, 14(1): 74-83.
3.	Guillem P, Bolla M, Courby S, et al. Multidisciplinary team meetings in cancerology: Setting priorities for improvement. Bull Cancer, 2011, 98(9): 989-998.
4.	Lamb BW, Brown KF, Nagpal K, et al. Quality of care management decisions by multidisciplinary cancer teams: A systematic review. Ann Surg Oncol, 2011, 18(8): 2116-2125.
5.	Lamb BW, Taylor C, Lamb JN, et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: Findings of a national study. Ann Surg Oncol, 2013, 20(5): 1408-1416.
6.	WHO. Latest global cancer data: Cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020. https://www.iarc.fr/faq/latest-global-cancer-data-2020-qa/.
7.	Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet, 2018, 391(10125): 1023-1075.
8.	Conron M, Phuah S, Steinfort D, et al. Analysis of multidisciplinary lung cancer practice. Intern Med J, 2007, 37(1): 18-25.
9.	Denton E, Conron M. Improving outcomes in lung cancer: The value of the multidisciplinary health care team. J Multidiscip Healthc, 2016, 9: 137-144.
10.	Boxer MM, Vinod SK, Shafiq J, et al. Do multidisciplinary team meetings make a difference in the management of lung cancer? Cancer, 2011, 117(22): 5112-5120.
11.	Clifton IJ, Scarsbrook AF, Muers MF. No lung cancer at resection of PET positive lesions: An audit of the lung cancer multidisciplinary team. Eur Respir J, 2009, 33(4): 941-942.
12.	Ellis PM. The importance of multidisciplinary team management of patients with non-small-cell lung cancer. Curr Oncol, 2012, 19(Suppl1): S7-S15.
13.	Stone E, Rankin N, Kerr S, et al. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study. Lung Cancer, 2018, 124: 199-204.
14.	Ung KA, Campbell BA, Duplan D, et al. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer. Asia Pac J Clin Oncol, 2016, 12(2): e298-e304.
15.	Boxer MM, Duggan KJ, Descallar J, et al. Do patients discussed at a lung cancer multidisciplinary team meeting receive guideline-recommended treatment? Asia Pac J Clin Oncol, 2016, 12(1): 52-60.
16.	Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ, 1995, 311(7010): 899-909.
17.	Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol, 2008, 26(21): 3552-3559.
18.	NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: A systematic review and meta-analysis of individual participant data. Lancet, 2014, 383(9928): 1561-1571.
19.	MacLean M, Luo X, Wang S, et al. Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: An analysis of the National Cancer Database. Oncotarget, 2018, 9(36): 24470-24479.
20.	中国抗癌协会肺癌专业委员会, 中华医学会肿瘤学分会肺癌学组, 中国胸部肿瘤研究协作组. Ⅰ~ⅢB期非小细胞肺癌完全切除术后辅助治疗指南(2021版). 中华医学杂志, 2021, 101(16): 1132-1142.
21.	中国临床肿瘤学会, 中国抗癌协会肺癌专业委员会. 早期肺癌围术期治疗专家共识. 循证医学, 2019, 19(4): 193-199.
22.	Ouwens MM, Hermens RR, Termeer RA, et al. Quality of integrated care for patients with nonsmall cell lung cancer: Variations and determinants of care. Cancer, 2007, 110(8): 1782-1790.
23.	Patkar V, Acosta D, Davidson T, et al. Cancer multidisciplinary team meetings: Evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer, 2011, 2011: 831605.

1. Devitt B, Philip J, McLachlan SA. Team dynamics, decision making, and attitudes toward multidisciplinary cancer meetings: Health professionals' perspectives. J Oncol Pract, 2010, 6(6): e17-e20.
2. Rankin NM, Lai M, Miller D, et al. Cancer multidisciplinary team meetings in practice: Results from a multi-institutional quantitative survey and implications for policy change. Asia Pac J Clin Oncol, 2018, 14(1): 74-83.
3. Guillem P, Bolla M, Courby S, et al. Multidisciplinary team meetings in cancerology: Setting priorities for improvement. Bull Cancer, 2011, 98(9): 989-998.
4. Lamb BW, Brown KF, Nagpal K, et al. Quality of care management decisions by multidisciplinary cancer teams: A systematic review. Ann Surg Oncol, 2011, 18(8): 2116-2125.
5. Lamb BW, Taylor C, Lamb JN, et al. Facilitators and barriers to teamworking and patient centeredness in multidisciplinary cancer teams: Findings of a national study. Ann Surg Oncol, 2013, 20(5): 1408-1416.
6. WHO. Latest global cancer data: Cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020. https://www.iarc.fr/faq/latest-global-cancer-data-2020-qa/.
7. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): Analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet, 2018, 391(10125): 1023-1075.
8. Conron M, Phuah S, Steinfort D, et al. Analysis of multidisciplinary lung cancer practice. Intern Med J, 2007, 37(1): 18-25.
9. Denton E, Conron M. Improving outcomes in lung cancer: The value of the multidisciplinary health care team. J Multidiscip Healthc, 2016, 9: 137-144.
10. Boxer MM, Vinod SK, Shafiq J, et al. Do multidisciplinary team meetings make a difference in the management of lung cancer? Cancer, 2011, 117(22): 5112-5120.
11. Clifton IJ, Scarsbrook AF, Muers MF. No lung cancer at resection of PET positive lesions: An audit of the lung cancer multidisciplinary team. Eur Respir J, 2009, 33(4): 941-942.
12. Ellis PM. The importance of multidisciplinary team management of patients with non-small-cell lung cancer. Curr Oncol, 2012, 19(Suppl1): S7-S15.
13. Stone E, Rankin N, Kerr S, et al. Does presentation at multidisciplinary team meetings improve lung cancer survival? Findings from a consecutive cohort study. Lung Cancer, 2018, 124: 199-204.
14. Ung KA, Campbell BA, Duplan D, et al. Impact of the lung oncology multidisciplinary team meetings on the management of patients with cancer. Asia Pac J Clin Oncol, 2016, 12(2): e298-e304.
15. Boxer MM, Duggan KJ, Descallar J, et al. Do patients discussed at a lung cancer multidisciplinary team meeting receive guideline-recommended treatment? Asia Pac J Clin Oncol, 2016, 12(1): 52-60.
16. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ, 1995, 311(7010): 899-909.
17. Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol, 2008, 26(21): 3552-3559.
18. NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: A systematic review and meta-analysis of individual participant data. Lancet, 2014, 383(9928): 1561-1571.
19. MacLean M, Luo X, Wang S, et al. Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: An analysis of the National Cancer Database. Oncotarget, 2018, 9(36): 24470-24479.
20. 中国抗癌协会肺癌专业委员会, 中华医学会肿瘤学分会肺癌学组, 中国胸部肿瘤研究协作组. Ⅰ~ⅢB期非小细胞肺癌完全切除术后辅助治疗指南(2021版). 中华医学杂志, 2021, 101(16): 1132-1142.
21. 中国临床肿瘤学会, 中国抗癌协会肺癌专业委员会. 早期肺癌围术期治疗专家共识. 循证医学, 2019, 19(4): 193-199.
22. Ouwens MM, Hermens RR, Termeer RA, et al. Quality of integrated care for patients with nonsmall cell lung cancer: Variations and determinants of care. Cancer, 2007, 110(8): 1782-1790.
23. Patkar V, Acosta D, Davidson T, et al. Cancer multidisciplinary team meetings: Evidence, challenges, and the role of clinical decision support technology. Int J Breast Cancer, 2011, 2011: 831605.

Previous Article
Treatment of pain in chronic pancreatitis
Next Article
Quality of life in 243 patients with primary palmar hyperhidrosis after endoscopic thoracic sympathicotomy

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

One-stop management of lung nodules and lung cancer: From multidisciplinary team to multidisciplinary doctor

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content